Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (201-210 of 464) with videos related to

Pageof 47
Sort By:
EJNMMI Research|June 1, 2017
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using <sup>111</sup>In-bevacizumabNeel Patel, Sarah Able, Danny Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
Cancer Research|March 15, 2008
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cellsCassin Kimmel Williams, Marta Segarra, Maria De La Luz Sierra, et al.
Arthritis Research & Therapy|June 26, 2003
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritisAlexandra Giatromanolaki, Efthimios Sivridis, Efstratios Maltezos, et al.
Histopathology|May 26, 2010
Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancerLucy Gossage, Abed Zaitoun, Khaleel R Fareed, et al.
Breast Cancer Research and Treatment|October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosisCecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
The Journal of Pathology|March 29, 2002
Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomasEfthimios Sivridis, Alexandra Giatromanolaki, Panagiotis Anastasiadis, et al.
Annals of the New York Academy of Sciences|October 23, 2009
Role of hypoxia-inducible factors in epigenetic regulation via histone demethylasesJun Yang, Ioanna Ledaki, Helen Turley, et al.
Cancer Research|September 3, 2004
CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alphaStephen B Fox, José Bragança, Helen Turley, et al.
Gynecologic Oncology|June 6, 2008
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancerAlexandra Giatromanolaki, Gaynor J Bates, Michael I Koukourakis, et al.
Pageof 47

Showing results (201-210 of 464) with videos related to

Sort By:
Pageof 47
EJNMMI Research|June 1, 2017
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using <sup>111</sup>In-bevacizumabNeel Patel, Sarah Able, Danny Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
Cancer Research|March 15, 2008
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cellsCassin Kimmel Williams, Marta Segarra, Maria De La Luz Sierra, et al.
Arthritis Research & Therapy|June 26, 2003
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritisAlexandra Giatromanolaki, Efthimios Sivridis, Efstratios Maltezos, et al.
Histopathology|May 26, 2010
Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancerLucy Gossage, Abed Zaitoun, Khaleel R Fareed, et al.
Breast Cancer Research and Treatment|October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosisCecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
The Journal of Pathology|March 29, 2002
Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomasEfthimios Sivridis, Alexandra Giatromanolaki, Panagiotis Anastasiadis, et al.
Annals of the New York Academy of Sciences|October 23, 2009
Role of hypoxia-inducible factors in epigenetic regulation via histone demethylasesJun Yang, Ioanna Ledaki, Helen Turley, et al.
Cancer Research|September 3, 2004
CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alphaStephen B Fox, José Bragança, Helen Turley, et al.
Gynecologic Oncology|June 6, 2008
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancerAlexandra Giatromanolaki, Gaynor J Bates, Michael I Koukourakis, et al.
Pageof 47